首页> 外国专利> Pharmaceutical compositions comprising a dextromethorphan compound and quinidine for the treatment of agitation in dementia

Pharmaceutical compositions comprising a dextromethorphan compound and quinidine for the treatment of agitation in dementia

机译:包含右美沙芬化合物和奎尼丁的药物组合物,用于治疗痴呆症中的躁动

摘要

The present disclosure is related to methods of treating agitation and/or aggression and/or associated symptoms in subjects with dementia, including, dementia associated with Alzheimer's disease. The method includes administering to a subject in need thereof a dextromethorphan compound, or a pharmaceutically acceptable salt thereof, in combination with quinidine, or a pharmaceutically acceptable salt thereof. The disclosure in certain aspects is also related to compositions that are used for treating agitation and/or aggression and/or associated symptoms in subjects suffering from Alzheimer's disease.
机译:本公开涉及治疗患有痴呆症的受试者,包括与阿尔茨海默氏病有关的痴呆症的躁动和/或攻击和/或相关症状的方法。该方法包括向需要其的受试者给予右美沙芬化合物或其药学上可接受的盐,与奎尼丁或其药学上可接受的盐组合。在某些方面,本公开还涉及用于治疗患有阿尔茨海默氏病的受试者的躁动和/或攻击和/或相关症状的组合物。

著录项

  • 公开/公告号IL250786D0

    专利类型

  • 公开/公告日2017-04-30

    原文格式PDF

  • 申请/专利权人 AVANIR PHARMACEUTICALS INC.;

    申请/专利号IL20170250786

  • 发明设计人

    申请日2017-02-26

  • 分类号A61K;

  • 国家 IL

  • 入库时间 2022-08-21 13:38:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号